SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-011510
Filing Date
2024-04-25
Accepted
2024-04-25 16:12:53
Documents
2
Period of Report
2024-04-25

Document Format Files

Seq Description Document Type Size
1 form3-04252024_080446.html 3  
1 form3-04252024_080446.xml 3 1742
2 ex24-04252024_080446.htm EX-24 6566
  Complete submission text file 0001415889-24-011510.txt   10023
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Krishnan Mahesh (Reporting) CIK: 0001866746 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32335 | Film No.: 24876440